Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study

Pediatric Blood and Cancer

Volumn 62, Issue 7, 2015, Pages 1190-1194

  Priola, Ginna M ^a   Foster, Matthew W ^b   Deal, Allison M ^a   Richardson, Brenna M ^b   Thompson, J Will ^b   Blatt, Julie ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ALL; Asparaginase; CSF; Proteomics; Thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 9; HEPARIN COFACTOR II; PLASMA PROTEIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROTHROMBIN; SERINE PROTEINASE INHIBITOR; UROKINASE; BIOLOGICAL MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CEREBROSPINAL FLUID; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUMBAR PUNCTURE; LYMPHOBLASTOMA; MALE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; SUPERIOR SAGITTAL SINUS; TANDEM MASS SPECTROMETRY; THROMBOSIS; TRANSVERSE SINUS; ADOLESCENT; ADULT; BRAIN DISEASES; COMPLICATION; FOLLOW UP; INFANT; NEWBORN; PROCEDURES; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PILOT PROJECTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; PROTEOMICS; TANDEM MASS SPECTROMETRY; THROMBOSIS; YOUNG ADULT;

EID: 84929378258     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25420     Document Type: Article

References (22)

1. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Gugliemo M, de Gaetano G, Donati MB. Thombotic complications in childhood acute lymphoblastic leukemia: A meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108:2216-2222.
2. Payne JH, Vora AJ. Thrombosis and acute lymphoblastic leukemia. Br J Hematol 2007; 138:430-445.
3. Raetz EA, Salzer WL. Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. J Pediat Hematol Onc 2010; 32:554-563.
4. Grace RF, Dahlberg SE, Neuberg D, Sallan SE, Connors JM, Neufeld EJ, DeAngelo DJ, Silverman LB. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 2011; 152:452-459.
5. Mitchell L, Lambers M, Flege S, Kenet G, Li-Thiao-Te V, Holzhauer S, Bidlingmater C, Frühwald MC, Heller C, Schmidt W, Pautard B, Nowak-Göttl U. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: Results of a multicenter cohort study. Blood 2010; 115:4999-5004.
6. Nowak-Göttl U, Kenet G, Mitchell LG. Thrombosis in childhood acute lymphoblastic leukaemia: Epidemiology, aetiology, diagnosis, prevention and treatment. Best Pract Res Cl Ha 2009; 22:103-114.
7. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia. Part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003; 111:125-131.
8. Wermes C, Prondzinski M, Licthinghagen R, Barthels M, Welte K, Sykora K-W. Clinical relevance of genetic risk factors for thrombosis in pediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158:S143-S146.
9. Roche S, Gabelle A, Lehmann S. Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers. Proteom Clin Appl 2008; 2:428-436.
10. Maurer MH. Proteomics of brain extracellular fluid (ECF) and Cerebrospinal fluid (CSF). Mass Spectrom Rev 2010; 29:17-28.
11. Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: Significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 1998; 57:885-894.
12. Hühmer AF, Biringer RG, Amato H, Fonteh A, Harrington MG. Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges. Dis Markers 2006; 22:3-26.
13. Hunger SP, Mignon LL, Whitlock JA, Winick NJ, Carroll WL, Devidas M, Raetz EA. Children's Oncology Group's 2013 blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer 2013; 60:957-963.
14. Foster MW, Thompson JW, Que LG, Que LG, Yang IV, Schwartz DA, Moseley MA, Marshall HE. Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J Proteome Res 2013; 12:2194-2205.
15. Athale UH, Siciliano SA, Crowther M, Barr RD, Chan AK. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: Effect of age and risk stratification of disease. Br J Haemotol 2005; 129:803-810.
16. Shores KS, Knapp DR. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J Proteome Res 2007; 6:3739-3751.
17. Maccarrone G, Milfay D, Birg I, Rosenhagan M, Holsboer F, Grimm R, Bailey J, Zolotarjova N, Turck CW. Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis 2004; 25:2402-2412.
18. Reidel B, Thompson JW, Farsiu S, Moseley MA, Skiba NP, Arshavsky VY. Proteomic profiling of a layered tissue reveals unique glycolytic specializations of photoreceptor cells. Mol Cell Proteomics 2011; 10:M110 002469.
19. Rau JC, Beaulieu LM, Huntington JA, Church FC. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007; 5:102-115.
20. Chan MY, Lin M, Lucas J, Moseley A, Thompson JW, Cyr D, Ueda H, Kajikawa M, Ortel TL, Becker RC. Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thromb Haemostasis 2012; 108:1180-1191.
21. Cyr DD, Lucas JE, Thompson JW, Patel K, Clark PJ, Thompson A, Tillmann HL, McHutchinson JG, Moseley MA, McCarthy JJ. Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PloS one 2011; 6:e21854.
22. Patel K, Lucas JE, Thompson JW, Dubois LG, Tillmann HL, Thompson AJ, Uzarski D, Califf RM, Moseley MA, Ginsburg GS, McHutchinson JG, McCarthy JJ. MURDOCK Horizon 1 Study Team. High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients. Hepatology 2011; 53:1809-1818.